|
Volumn 39, Issue 10, 2007, Pages 3109-3110
|
Cyclosporine Monitoring in Peripheral Blood Mononuclear Cells: Feasibility and Interest. A Prospective Study on 20 Renal Transplant Recipients
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CD4 ANTIGEN;
CYCLOSPORIN A;
CYTOKINE;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
CD4+ T LYMPHOCYTE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG DISTRIBUTION;
DRUG DOSE REDUCTION;
DRUG MONITORING;
DRUG POTENCY;
DRUG WITHDRAWAL;
FEASIBILITY STUDY;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE;
MONOCYTE;
NEPHROTOXICITY;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RECIPIENT;
TREATMENT OUTCOME;
ADULT;
AGED;
CYCLOSPORINE;
FOLLOW-UP STUDIES;
HUMANS;
KIDNEY TRANSPLANTATION;
LEUKOCYTE COUNT;
LEUKOCYTES, MONONUCLEAR;
MIDDLE AGED;
MONITORING, PHYSIOLOGIC;
PROSPECTIVE STUDIES;
|
EID: 37048998528
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2007.03.103 Document Type: Article |
Times cited : (14)
|
References (7)
|